IDH1 and astrocytoma (excluding glioblastoma): For example, GBM IDH-wt carry EGFR amplifications in around 45% [15] and TERT mutations in up to 80% [16] while astrocytomas with an IDH mutation exhibit such alterations in a rather low number [12].